Búsqueda avanzada

Autores/as cuyas obras están en dominio público en al menos una jurisdicción

Lista de obras de Dylan M. Glubb

Identification of a Locus Near <i>ULK1</i> Associated With Progression-Free Survival in Ovarian Cancer

publication published on 23 June 2021

Data from Genetic Variants of &lt;i&gt;VEGFA&lt;/i&gt; and &lt;i&gt;FLT4&lt;/i&gt; Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with Sorafenib

Enhancer plasticity in endometrial tumorigenesis demarcates non-coding somatic mutations and 3D-genome alterations boosting the oncogenic driver ESR1

Figure S1 from Genetic Variants of &lt;i&gt;VEGFA&lt;/i&gt; and &lt;i&gt;FLT4&lt;/i&gt; Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with Sorafenib

Figure S1 from Genetic Variants of &lt;i&gt;VEGFA&lt;/i&gt; and &lt;i&gt;FLT4&lt;/i&gt; Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with Sorafenib

Figure S3 from Genetic Variants of &lt;i&gt;VEGFA&lt;/i&gt; and &lt;i&gt;FLT4&lt;/i&gt; Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with Sorafenib

Figure S5 from Genetic Variants of &lt;i&gt;VEGFA&lt;/i&gt; and &lt;i&gt;FLT4&lt;/i&gt; Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with Sorafenib

Genetic analyses of gynecological disease identify genetic relationships between uterine fibroids and endometrial cancer, and a novel endometrial cancer genetic risk region at the WNT4 1p36.12 locus

Mendelian Randomisation Analysis Suggests that Hypothyroidism Reduces Endometrial Cancer Risk

Multi-tissue transcriptome-wide association study identifies genetic mechanisms underlying endometrial cancer susceptibility

Risk Stratification for Endometrial Cancer Reveals Independent Contributions of Polygenic Risk and Body Mass Index

SpliceAI-10k calculator for the prediction of pseudoexonization, intron retention, and exon deletion

Splicing annotation of endometrial cancer GWAS risk loci reveals potentially causal variants and supports a role forNF1andSKAP1as susceptibility genes

Supplementary Methods and Materials from Genetic Variants of &lt;i&gt;VEGFA&lt;/i&gt; and &lt;i&gt;FLT4&lt;/i&gt; Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with Sorafenib

Table S1 from Genetic Variants of &lt;i&gt;VEGFA&lt;/i&gt; and &lt;i&gt;FLT4&lt;/i&gt; Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with Sorafenib

Table S1 from Genetic Variants of &lt;i&gt;VEGFA&lt;/i&gt; and &lt;i&gt;FLT4&lt;/i&gt; Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with Sorafenib

Dominio Público Uruguay cuenta con el apoyo de:

Acerca de Dominio Público Uruguay

Ayuda